The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (+/-)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (+/-)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.

Chiral switches of tramadol hydrochloride, a potential psychedelic drug. Past and future / Agranat, Israel; D'Acquarica, Ilaria. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - (2024). [10.1021/acsmedchemlett.4c00322]

Chiral switches of tramadol hydrochloride, a potential psychedelic drug. Past and future

D'Acquarica, Ilaria
2024

Abstract

The chiral opioid analgesic tramadol was patented (1962) as a cis- and trans-racemates mixture. A first chiral switch led to the (+/-)-cis-(1RS,2RS) racemate, patented and approved as Tramal (1980), preferred over the (+)-cis-(1R,2R)-enantiomer. Consecutive chiral switches of (+/-)-cis-tramadol to (+)-cis-(1R,2R)-tramadol/salts were patented. This Viewpoint calls for developing (+)-cis-(1R,2R)-tramadol medicines and recognizing tramadol medicines as potential psychedelics to overcome the spreading tramadol crisis.
2024
tramadol; chiral switch; patents; stereochemistry; psychedelic; opioid crisis; analgesics
01 Pubblicazione su rivista::01a Articolo in rivista
Chiral switches of tramadol hydrochloride, a potential psychedelic drug. Past and future / Agranat, Israel; D'Acquarica, Ilaria. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - (2024). [10.1021/acsmedchemlett.4c00322]
File allegati a questo prodotto
File Dimensione Formato  
Agranat_Chiral_2024.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.24 MB
Formato Adobe PDF
1.24 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1717591
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact